HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 7
  • 8
  • 9
  • 10
  • 11
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Ou Xiaobing
    Ou Xiaobing
    Specializes in minimally invasive interventional therapy for solid tumors such as liver cancer, lung cancer, and tumors of the head, neck, and digestive tract. Proficient in techniques including ablation, seed implantation, and stent placement, with extensive experience in managing malignant pleural and peritoneal effusions and preventing/treating postoperative complications.
    Profile:
    Fosun Cancer Hospital Guangzhou, Ou Xiaobing, Attending Physician in the Department of Comprehensive Oncology at Guangzhou Fosun Chancheng Hospital and Council Member of the China Maternal and Child Interventional Alliance. With nearly a decade of experience in specialized oncology and peripheral vascular interventional therapy, he has performed over 4,000 interventional procedures. He specializes in minimally invasive interventional therapy for solid tumors—such as liver cancer, lung cancer, and tumors of the head, neck, and digestive tract—and is proficient in techniques including ablation, seed implantation, and stent placement.
  • Cheng Hongying
    Cheng Hongying
    Has over 30 years of experience in oncology nursing. Specializes in ultrasound-guided PICC placement, port-a-cath maintenance, and complication management. Possesses extensive experience in the care of oncological wounds, stomas, and lymphedema, as well as in palliative/hospice care; honored with the title of "Most Beautiful Hometown Person" (a national recognition).
    Profile:
    Fosun Cancer Hospital Guangzhou, Cheng Hongying, Head Nurse and Associate Chief Nurse at the Precision Oncology Diagnosis and Treatment Center, Foshan Fosun Chancheng Hospital. She is a committee member of the Hospice Care Professional Committee of the Guangdong Nursing Association and Vice-Chair of the Oncology Nursing Professional Committee of the Foshan Nursing Association. With over 30 years of clinical nursing experience, she specializes in PICC catheterization, infusion port maintenance, and complication management, and possesses extensive experience in managing oncological wounds, stomas, lymphedema, and hospice care.
  • Qin Jiamin
    Qin Jiamin
    With 18 years of experience in PET/CT diagnostics, this specialist excels in differentiating between benign and malignant tumors, tumor staging, and evaluating treatment efficacy.They have been honored with the title of "Anti-Epidemic Hero."
    Profile:
    Fosun Cancer Hospital Guangzhou, Qin Jiamin, Attending Physician at the PET/CT Center of Foshan Fosun Chancheng Hospital. Holding a postgraduate degree in Medical Imaging and Nuclear Medicine, she has 18 years of experience in PET/CT diagnostics. She specializes in the differential diagnosis of benign and malignant tumors, clinical staging, and treatment efficacy assessment, possessing extensive expertise in the application of PET/CT molecular imaging technology for precision tumor diagnosis.
  • Li Jinyu
    Li Jinyu
    Specializes in the diagnosis and treatment of hematologic and lymphatic diseases, with extensive experience in managing various types of anemia, leukopenia, and thrombocytopenia.Participates in cutting-edge immunotherapy projects such as CAR-T cell therapy and is dedicated to providing precise, personalized treatment for patients with hematologic malignancies.
    Profile:
    Fosun Cancer Hospital Guangzhou, Li Jinyu, Attending Physician at the Precision Oncology Diagnosis and Treatment Center of Foshan Fosun Chancheng Hospital. Specializes in the diagnosis and treatment of lympho-hematological diseases, with extensive experience in treating anemia, leukopenia, and thrombocytopenia; participates in immunotherapy programs such as CAR-T cell therapy, providing precise, personalized treatment for patients with hematological malignancies such as lymphoma and myeloma.
  • Shi Xiubo
    Shi Xiubo
    Has nearly 10 years of experience in clinical oncology and research. Specializes in radiotherapy and comprehensive treatment for common tumors, with particular expertise in the radiotherapy of digestive and urinary system tumors as well as rare malignancies.
    Profile:
    Fosun Cancer Hospital Guangzhou, Shi Xiubo, Attending Physician at the Precision Oncology Center of Foshan Fosun Chancheng Hospital. With nearly 10 years of experience in clinical oncology and research, he specializes in radiotherapy and comprehensive treatment for common tumors. He possesses extensive experience—particularly in the radiotherapy of digestive system tumors, urinary system tumors, and rare malignancies—and emphasizes personalized, comprehensive treatment strategies.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 7
  • 8
  • 9
  • 10
  • 11

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.